The Chinese STEMI PPCI Registry (CSPR)

Wuhan University

Status: Completed

Conditions: ST-segment Elevation Myocardial Infarction (STEMI)

Treatments: Other: no intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04996901

958374

Details and patient eligibility

About

The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.

Full description

The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.

Enrollment: 5,594 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age≥18
2. ST-segment elevation myocardial infarction was defined according to the universal definition of myocardial infarction
3. STEMI treated by pPCI

Exclusion criteria

1. Patient with heart failure in admission
2. STEMI with symptom-onset-to-balloon time>24h
3. pPCI was not successful or only underwent coronary angiography
4. Killip class ≥II in admission

Trial design

5,594 participants in 2 patient groups

derivation cohort

Description:

Data from Renmin Hospital of Wuhan University, The First College of Clinical Medical Science, China Three Gorges University, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Xiangyang No.1 People's Hospital，and Wuhan Third Hospital will be used as a derivation cohort.

Treatment:

Other: no intervention

validation cohort

Description:

Data from The First Affiliated Hospital of Dalian Medical University and Jiangxi Provincial People's Hopital will be used as a derivation cohort.

Treatment:

Other: no intervention